Fisher Wallace Laboratories

Fisher Wallace Laboratories, based in Brooklyn, NY, is at the forefront of wearable brain stimulation technology, with a focus on improving mental health through innovative devices. Their upcoming product, OAK, is designed to provide lifelong brain health and has shown promising results in clinical trials for treating depression and anxiety.

Founded by Kelly Roman and Chip Fisher, the company has a strong emphasis on clinical research and regulatory affairs, collaborating with notable institutions such as Massachusetts General Hospital and the Seattle Police Department. With a commitment to patient advocacy and groundbreaking technology, Fisher Wallace Laboratories aims to revolutionize mental health treatment through its advanced neuromodulation devices.

Generated from the website